Just as the CBD industry was hoping to start work next month on the cannabinoid’s place in food, drugs and cosmetics, the head of the U.S. Food and Drug Administration chief is resigning. Dr. Scott Gottlieb, who told Congress last week that CBD can’t be added to consumer products, is leaving office in April, according […]
Report: FDA chief to resign, leaving CBD review in question is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
Read More: Report: FDA chief to resign, leaving CBD review in question
Comments are closed, but trackbacks and pingbacks are open.